| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | -0.0025 | 1 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.003 | 1 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | -0.0053 | 1 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | 0.0014 | 1 |